drugset / Trial / NCT05198336
Immunogenicity of an Inactivated COVID-19 Vaccine
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This study is an open phase 4 clinical trial of an inactivated COVID-19 vaccine (CoronaVac) manufactured by Sinovac Research and Development Co., Ltd. The purpose of this study is to evaluate the immunogenicity of the CoronaVac in healthy children aged 3-11 years old.
Timeline
- Start
- 2022-01-08
- Primary completion
- 2022-01-24
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CoronaVac | Vaccine | 600 unknown | — |